Timothy Edwin Kelly - 24 Mar 2023 Form 4/A - Amendment Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role: Chief Financial Officer
Signature: /s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol: PRAX
Transactions as of: 24 Mar 2023
Net transactions value: +$6,998
Form type: 4/A - Amendment
Filing time: 06 Apr 2023, 17:43:21 UTC
Date Of Original Report: 27 Mar 2023
Previous filing: 13 Jan 2023
Next filing: 18 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRAX	Common Stock	Purchase	$6,998	+8,000	+21%	$0.8747	46,416	24 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.861 to $0.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.

Remarks:

This amended Form 4 is being filed to correct the code in column 4 of Table I to indicate that the shares were acquired.